NCT00792909View on ClinicalTrials.gov

Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A

PHASE3CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

December 2, 2008

Primary Completion Date

July 2, 2009

Study Completion Date

July 2, 2009

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal conjugate vaccine GSK1024850A

Intramuscular injection, 1 dose

BIOLOGICAL

Pneumococcal conjugate vaccine GSK1024850A

Intramuscular injection, 2 doses

Trial Locations (5)

027 55

GSK Investigational Site, Dlhá nad Oravou

026 01

GSK Investigational Site, Dolný Kubín

034 01

GSK Investigational Site, Ružomberok

SE-701 16

GSK Investigational Site, Örebro

SE-901 85

GSK Investigational Site, Umeå

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00792909 - Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A | Biotech Hunter | Biotech Hunter